BusinessMedical Marijuana, Inc.’s HempMeds® Presenting Sponsor of Hemp Cannabidiol (CBD) Products at Celebrity Suite During 2016 MTV Movie AwardsBy Nasdaq OMXApr 1, 2016, 12:32 AM UTC
BusinessMedical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Notified of DEA Clearance for Import of High-Purity, Pharmaceutical-Grade Cannabidiol (CBD)By Nasdaq OMXMar 1, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc.’s New Cannabis-Derived Compound KLS-13019 Covered by Reuters, Kannalife Explores IPO This YearBy Nasdaq OMXFeb 26, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc.'s RSHO-X Garners FOX 5, Other Global News Coverage After News of Historic Import Permits for Mexican FamiliesBy Nasdaq OMXFeb 12, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc.'s CEO on Union Tribune Radio Discussing International Cannabis Law Changes, US Cannabis Exports: RSHO and RSHO-X Cannabidiol (CBD) ProductsBy Nasdaq OMXFeb 11, 2016, 2:00 PM UTC
BusinessMedical Marijuana Inc.’s CEO Delivers Historic Keynote Address on Cannabidiol (CBD) at VII Mexico City World Anti-Aging CongressBy Nasdaq OMXFeb 10, 2016, 4:30 PM UTC
BusinessMedical Marijuana, Inc. Announces the Launch of HempMeds® Mexico: Opening the Cannabidiol (CBD) Market to the Country’s More Than 122 Million ResidentsBy Nasdaq OMXFeb 4, 2016, 6:30 PM UTC
BusinessMedical Marijuana, Inc.’s RSHO-X: Government of Mexico Approves Historic First Import Permits for Cannabidiol (CBD) Oil – Permits Now Available Via COFEPRISBy Nasdaq OMXFeb 2, 2016, 7:37 PM UTC